These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 32552297)
1. Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Li C; Li ZC; Ma L; Li LQ; Zhong JH; Xiang BD; Gong WF Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):749-756. PubMed ID: 32552297 [TBL] [Abstract][Full Text] [Related]
2. Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg-negative hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis. Sun T; Qiu Y; Wang T; Yang Y; Qiu H; Shen S; Pang H; Wang W Cancer Med; 2024 Aug; 13(16):e70185. PubMed ID: 39219190 [TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis. Xu M; Zhou Z; Xu R; Zhang H; Lin N; Zhong Y World J Surg Oncol; 2019 Mar; 17(1):45. PubMed ID: 30823932 [TBL] [Abstract][Full Text] [Related]
4. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma. Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361 [TBL] [Abstract][Full Text] [Related]
5. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358 [TBL] [Abstract][Full Text] [Related]
7. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026 [TBL] [Abstract][Full Text] [Related]
8. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib. Yang Y; Wen F; Li J; Zhang P; Yan W; Hao P; Xia F; Bi F; Li Q Liver Int; 2015 Sep; 35(9):2147-54. PubMed ID: 25676812 [TBL] [Abstract][Full Text] [Related]
9. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma. Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614 [TBL] [Abstract][Full Text] [Related]
10. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma. Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625 [TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort. Sakamoto K; Beppu T; Hayashi H; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Isiko T; Kikuchi K; Baba H Anticancer Res; 2015 Mar; 35(3):1647-55. PubMed ID: 25750323 [TBL] [Abstract][Full Text] [Related]
12. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma. Chong CC; Wong GL; Lai PB World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723 [TBL] [Abstract][Full Text] [Related]
13. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma. Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445 [TBL] [Abstract][Full Text] [Related]
14. Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablation. Qi W; Zhang Q; Xu Y; Wang X; Yu F; Zhang Y; Zhao P; Guo H; Zhou C; Wang Z; Sun Y; Liu L; Xuan W; Wang J J Viral Hepat; 2020 Apr; 27(4):387-396. PubMed ID: 31755220 [TBL] [Abstract][Full Text] [Related]
15. Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study. Yan PG; Wang RY; Zhang J; Cong WM; Dong H; Yu HY; Lau WY; Wu MC; Zhou WP J Gastrointest Surg; 2018 May; 22(5):872-883. PubMed ID: 29313290 [TBL] [Abstract][Full Text] [Related]
16. Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study. Sun F; Liu Z; Wang B BMC Cancer; 2021 Oct; 21(1):1103. PubMed ID: 34649509 [TBL] [Abstract][Full Text] [Related]
17. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection. Chen JL; Lin XJ; Zhou Q; Shi M; Li SP; Lao XM Chin J Cancer; 2016 Mar; 35():28. PubMed ID: 26992891 [TBL] [Abstract][Full Text] [Related]
18. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455 [TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study. Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631 [TBL] [Abstract][Full Text] [Related]
20. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]